Tag: clinical operations

Ethics Governance in Global Multi-Region Clinical Trials: Structures and Roles

November 15, 2025November 14, 2025 digi

Ethics Governance in Global Multi-Region Clinical Trials: Structures and Roles Ethics Governance in Global Multi-Region Clinical Trials: Structures and Roles Conducting pharmaceutical clinical trials across multiple regions such as the US, UK, and EU requires a comprehensive understanding of the ethics governance structures and roles involved. These structures ensure that the trials are compliant with…

Ethics in Global Multi-Region Trials

Harmonizing Ethics Committee Requirements Across US, UK and EU Sites

November 15, 2025November 14, 2025 digi

Harmonizing Ethics Committee Requirements Across US, UK and EU Sites In an era where global collaboration in clinical trials is becoming a norm, understanding the variances in ethics committee requirements across regions is crucial. This guide provides a comprehensive, step-by-step tutorial on how to navigate and harmonize ethics committee processes between the United States (US),…

Ethics in Global Multi-Region Trials

Managing Country-Specific Ethics Rules in Global Protocol Development

November 15, 2025November 14, 2025 digi

Managing Country-Specific Ethics Rules in Global Protocol Development Managing Country-Specific Ethics Rules in Global Protocol Development In the rapidly evolving landscape of clinical research, specifically in global multi-region trials, managing country-specific ethics can be challenging. Protocol developers must consider not only the scientific validity and operational feasibility of their clinical trials but also the ethical…

Ethics in Global Multi-Region Trials

Global Trials in Emerging Markets: Ethics, Oversight and Local Standards

November 15, 2025November 14, 2025 digi

Global Trials in Emerging Markets: Ethics, Oversight and Local Standards Global Trials in Emerging Markets: Ethics, Oversight and Local Standards As the landscape of pharma clinical trials evolves, many organizations are expanding their research initiatives into emerging markets. This article aims to provide clinical operations, regulatory affairs, and medical affairs professionals with a comprehensive step-by-step…

Ethics in Global Multi-Region Trials

Cross-Border Data Transfers and Ethics Committee Review

November 15, 2025November 14, 2025 digi

Cross-Border Data Transfers and Ethics Committee Review With the increasing globalization of clinical trials, managing ethical considerations across different jurisdictions has become a paramount concern for clinical research professionals. The intricacies surrounding cross-border data transfers and ethics committee reviews necessitate a comprehensive understanding of regulatory frameworks in the US, UK, and EU. This guide presents…

Ethics in Global Multi-Region Trials

Transparency About Data Sharing With Regulators, Sponsors and Third Parties

November 15, 2025November 14, 2025 digi

Transparency About Data Sharing With Regulators, Sponsors and Third Parties In the highly regulated landscape of clinical research, transparency about data sharing is not merely a best practice; it is an essential component of ethical conduct and compliance. Clinical trials involve multi-faceted collaborations among sponsors, regulators, and various third parties, requiring that all stakeholders fully…

Privacy, Confidentiality & Secondary Use

Anonymization vs Pseudonymization: Choosing Approaches for Global Programs

November 15, 2025November 14, 2025 digi

Anonymization vs Pseudonymization: Choosing Approaches for Global Programs Anonymization vs Pseudonymization: Choosing Approaches for Global Programs The management of sensitive personal data is a critical aspect of conducting clinical trials, especially in light of recent regulatory developments across the US, UK, and EU. The principles of privacy and confidentiality must be rigorously upheld, not only…

Privacy, Confidentiality & Secondary Use

Ethics Committee Expectations on Privacy Risk Assessment and Mitigation

November 15, 2025November 14, 2025 digi

Ethics Committee Expectations on Privacy Risk Assessment and Mitigation Ethics Committee Expectations on Privacy Risk Assessment and Mitigation 1. Introduction to Privacy Risk in Clinical Trials Clinical trials, particularly those involving sensitive health data, necessitate rigorous evaluations of privacy risks. The integration of ethical considerations is essential to protect participants’ information and ensure compliance with…

Privacy, Confidentiality & Secondary Use

Biobank Governance and Secondary Use of Stored Specimens

November 15, 2025November 14, 2025 digi

Biobank Governance and Secondary Use of Stored Specimens Biobanks have become invaluable resources for advancing research, particularly in the context of clinical trials. As the use of stored specimens for secondary research purposes increases, so too does the need to address complex issues surrounding governance, privacy, and ethical considerations. This article delivers a comprehensive step-by-step…

Privacy, Confidentiality & Secondary Use

Public Registries, Data Repositories and Participant Expectations of Privacy

November 15, 2025November 14, 2025 digi

Public Registries, Data Repositories and Participant Expectations of Privacy In the domain of clinical trials, managing participant data with both efficacy and ethics is paramount. The advent of numerous public registries and data repositories has created new frameworks for how data is collected, stored, and utilized within clinical trial management. This article directs clinical operations,…

Privacy, Confidentiality & Secondary Use